Women are disproportionately affected by issues surrounding health, as health decision-makers, caregivers, and patients. Women make 80 percent of health-care decisions for their families, and they are much more likely to serve as the primary caregiver for a family member who falls ill. Women also utilize more health-care services than men, accounting for 57 percent of all doctors’ office expenses. On top of that, women make up close to 80 percent of the health workforce. Yet only one Fortune 500 health-care company has a female CEO, and only 23 percent of executives at Fortune 500 health-care companies are women. Despite decades of mandates from Congress, women still make up less than half of clinical trial participants, and gender differences in outcomes are still inadequately studied. What initiatives are currently in place to ensure medical research and healthcare are reflecting the perspectives and priorities of women moving forward? What can all leaders do to further promote the inclusion of women at the leadership level of major health-care companies? How can industry shifts towards gender equity positively affect global health?
Moderator
Joanne Kenen
Executive Editor, Health Care, POLITICO
Speakers
Janine Austin Clayton
Director, Office of Research on Women’s Health, National Institutes of Health
Isabella Danel
Deputy Director, Pan American Health Organization
Freda Lewis-Hall
Executive Vice President and Chief Medical Officer, Pfizer
Saralyn Mark
Founder and President, iGIANT; first Senior Medical Advisor to the Office on Womens Health, Department of Health and Human Services and NASA
Paula Schneider
President and CEO, Susan G. Komen
#MIFHS
Learn more:
source
